WHAT IS ACTINICA?
Actinica is Australia’s first Liposomal Sunscreen that is clinically tested to help prevent non melanoma skin cancer. It is designed for patients who are at the highest risk of developing skin cancer.
HIGH RISK PATIENTS
- Organ transplant patients
- Patients on immunosuppressant drugs eg Imuran
- Patients on treatment for active rheumatoid arthritis
- HIV positive patients on concomitant medication
- Patients who are UVA sensitive due to treatment with drugs like Roaccutane
- Patients who have a history of skin cancer themselves or in their family
HOW DOES ACTINICA WORK?
- Unique Liposomal base encapsulates 6 UVA and UVB filters to the top layer of skin maximising protection where it is most effective
- Highest level of protection against UVA and UVB in Australia
- Actinica has been tested to achieve a level of SPF 105+ (Maximum allowable claim in Australia is SPF 30+)
- Sun filters work by absorbing, reflecting and scattering UV radiation.
- Supported by clinical trials as published in the British Journal of Dermatology.
ACTINICA’S UV PROTECTION
- Actinica® provides higher protection against UVA and UVB than other commercially available sunscreens in Australia.
- Actinica has been tested to achieve SPF 105+. (Maximum allowable claim in Australia is SPF 30+)
- SPF only relates to UVB, not UVA which is responsible for cellular DNA damage.
IN SUMMARY
- Clinically proven in trials (British Journal of Dermatology)
- Free from fragrance and PEG emulsifiers (ensuring tolerance for all skin types)
- Safe – no Nano particles of Zinc or Titanium
- Consumer compliance – excellent texture
- Consistent measured dosage – airless pump
- Ongoing usage – not only summer dependent